Medlab Clinical (Medlab Clinical) Total Stockholders Equity : $-0.47 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Medlab Clinical Total Stockholders Equity?

Medlab Clinical's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-0.47 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Medlab Clinical's Book Value per Share for the quarter that ended in Dec. 2023 was $-0.21. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Medlab Clinical's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.00.

Medlab Clinical Total Stockholders Equity Historical Data

The historical data trend for Medlab Clinical's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlab Clinical Total Stockholders Equity Chart

Medlab Clinical Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Stockholders Equity

Get a 7-Day Free Trial

10.45

7.87

11.58

5.68

0.86

Medlab Clinical Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial												8.70	5.68	2.20	0.86	-0.47

Medlab Clinical (OTCPK:MDBBF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Medlab Clinical's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-0.469	-	0)	/	2.2835
	=	-0.21

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Medlab Clinical's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	-0.469
	=	0.00

Medlab Clinical Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Medlab Clinical's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Medlab Clinical (Medlab Clinical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medlab Clinical Ltd (OTCPK:MDBBF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

11 Lord Street, Unit 5, Botany, NSW, AUS, 2019

Website

https://www.medlab.co

Medlab Clinical Ltd is a medical research and development company. It is engaged in researching and formulating novel biotherapeutics to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease, pre-diabetes, and obesity. Some of the company's nutraceutical products are Multibiotic, Mg Optima Relax, NRGBiotic, NanoCelle D3, SB 5B and others. The principal segments of the group are Nutraceutical which includes the sale of nutraceutical products; and Pharmaceutical research. It generates the majority of the revenue from the sale of nutraceutical products. The business operations of the firm are carried out from Australia.